Home > Press > ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications
Abstract:
ATTOPSEMI Technology, Ltd. today announced that it has joined GLOBALFOUNDRIES’ FDXcelerator™ Partner Program, to provide a scalable, non-volatile one-time programmable (OTP) memory IP to be compatible with GF’s 22FDX® technology. ATTOPSEMI’s leading-edge I-fuse™ OTP IP offers increased reliability, smaller cell size, low programming voltage/current, and high data security enabling customers and designers the ability to utilize an advanced OTP for harsh applications such as automotive, 3D IC, and IoT applications.
The opportunity for advanced OTP memory technology is greater than ever. As the volumes and technical demands increase for Internet of Things (IoT), processing performance grows and memory intensive applications advance, ATTOPSEMI’s I-fuse™ fills the need. Consumer, communications, automotive and wireless markets require smaller sizing, ease of programmability and high levels of reliability. With its patent-proven structure, the I-fuse™ can guarantee zero-program defect giving customers the needed knowledge of reliability and execution.
“ATTOPSEMI's new offering should benefit our 22FDX customers in all the key market segments we address, especially for IoT and processor intensive applications,” said Alain Mutricy, senior vice president of product management at GF. “Their commitment continues to demonstrate strong industry interest in GF's FDXcelerator program and the 22FDX value proposition.”
“We are excited to expand our engagements with GF and believe that our technology will help their customers deliver the functionality the market has been asking for,” said Chung Shine, Chairman, ATTOPSEMI. “We believe that our development has given us the ability to generate a smaller cell size and more reliability than our competitors along with a very scalable solution.”
ATTOPSEMI’s I-fuse™ is a fuse-based OTP technology that offers up to 100x reliability, 1/100 the cell size, and 1/10th the program current than traditional e-fuse technologies. Highlights of the I-fuse™ include:
Limited program current below a catastrophic breaking point
Use of junction diode, instead of MOS, as a program selector in an OTP cell
Smaller cell improving program efficiency enabling program current reduction
ABOUT ATTOPSEMI TECHNOLOGY
Founded in 2010, Attopsemi Technology is dedicated to developing and licensing fuse-based One-Time Programmable (OTP) Memory IP for all CMOS process technologies from 0.7um to 7nm and beyond. Attopsemi's proprietary I-fuse™ OTP technologies have been proven in numerous CMOS technologies and in several silicon foundries worldwide. For more information about the company and its products, please visit www.attopsemi.com.
####
For more information, please click here
Contacts:
ATTOPSEMI
CL Tai
Copyright © GLOBALFOUNDRIES
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Internet-of-Things
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New nanowire sensors are the next step in the Internet of Things January 6th, 2023
New chip ramps up AI computing efficiency August 19th, 2022
Lightening up the nanoscale long-wavelength optoelectronics May 13th, 2022
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Automotive/Transportation
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||